US 11236335
Selective antisense compounds and uses thereof
granted A61PA61P25/14A61P25/28
Quick answer
US patent 11236335 (Selective antisense compounds and uses thereof) held by Ionis Pharmaceuticals, Inc. expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 24
- CPC classes
- A61P, A61P25/14, A61P25/28